Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Merrion amends IPO

Merrion (Wilmington, Del.) amended its IPO and hopes to sell 4 million

Read the full 122 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE